Rethinking Clinical Trials

AUGUST 4, 2022

TOGETHER, COVID-19, Peginterferon Lambda. TOGETHER is a randomized adaptive platform trial that was initiated in June 2020 to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. It was a big treatment effect observed in a predominantly vaccinated population. Key Points.

Trials 130

Trials Vaccination Vaccine Clinical Trials 130

World of DTC Marketing

JULY 20, 2022

Pfizer, for instance, hiked the cost of its leukemia medication Besponsa again this month, bringing its per-vial price tag to $21,056. “This is PPfizer’sfourth hike on the cancer drug during the Covid-19 pandemic—even as the company enjoys record-shattering profits from its vaccine,” “the analysis notes.

Packaging 183

Packaging Packaging Drugs Vaccination 183

The Pharma Data

JANUARY 31, 2021

Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial. The candidate vaccines were given in two doses, three weeks apart. No serious adverse events related to the vaccine candidates studied were reported.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Pharma Tutor

NOVEMBER 19, 2021

We have also exported more than 65 million doses of COVID vaccines to nearly 100 countries this year. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic. Fri, 11/19/2021 - 16:19. Pharmapedia.

Pharmacy 52

Pharmacy Vaccination Vaccine Medicine 52

World of DTC Marketing

SEPTEMBER 9, 2021

A study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke, and type 2 diabetes. Then there is the cost of people who refuse to get vaccinated against COVID. Then there is the cost of unhealthy Americans.

Drugs 222

Drugs Pharmacy Clinical Trials Clinical Trials 222

The Pharma Data

NOVEMBER 29, 2021

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). All variants of COVID-19, including the Delta variant that is dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key.

Vaccination 52

Vaccination Vaccine Genome Genomics 52

The Pharma Data

DECEMBER 3, 2020

The Phase 1 trial was a randomized, observer-blind, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of the adjuvanted COVID-19 S-Trimer vaccine candidates formulated with different antigen levels. No serious adverse events related to the vaccine candidates studied were reported.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif.

Vaccination 52

Vaccination Vaccine Trials Protein 52

XTalks

NOVEMBER 27, 2021

The technical advisory group on SARS-CoV-2 virus evolution (TAG-VE) met on Friday to discuss B.1.1.529, The new variant was seen to be a cause of one of three major peaks in COVID-19 cases, one of the most recent of which is caused by the Delta variant. Related: FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Kids 5 to 11.

Vaccination 97

Vaccination Vaccine Protein Scientist 97

The Pharma Data

MAY 7, 2021

Johnson & Johnson COVID-19 Vaccinations Resume Following CDC and FDA Decision. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. See more information and instructions on how to setup the tag on: [link] >. Skip to content. Learn More.

Branding 52

Branding Vaccination Vaccine Development 52

pharmaphorum

SEPTEMBER 15, 2020

Pharma’s go-to-market strategies have tended to be more traditional than those seen in non-regulated sectors, but there are some signs this is changing, with an acceleration in the pace of change forced by the COVID-19 pandemic that is allowing the industry to close its gap with faster, more nimble consumer brands. Jeremy Richter, Tag.

Branding 109

Branding Marketing Pharma Companies Life Science 109

Delveinsight

FEBRUARY 23, 2021

The company develops transformative biologics including vaccines and therapeutics for the world’s most debilitating diseases. The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform.

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

XTalks

MARCH 22, 2023

Pfizer is also the co-developer of what is arguably the most successful COVID-19 vaccine rollout. Top-Selling Drugs by Year It’s no surprise that the best-selling drug of 2022 was Pfizer/BioNTech’s COVID-19 vaccine, Comirnaty (COVID-19 vaccine, mRNA).

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Intouch Solutions

JULY 27, 2021

they pointed out that the COVID-19 vaccines, and the controversial approval of aducanumab for the treatment of Alzheimer’s disease, represented polar opposites in terms of drug pricing reform. In the case of the vaccines, the U.S. In their letter, “ Drug Pricing Reform in 2021 – Going Big or Going Bipartisan?

Drugs 52

Drugs Marketing Vaccination Vaccine 52

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Development 52

Development Drugs Clinical Development Antibody 52

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. There is no easy answer to the question of how to incentivise innovation without restricting access.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

JANUARY 31, 2023

With the recent rapid rollout of Covid-19 vaccines, many people have raised questions about whether adequate research was conducted on these vaccines before approval. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products.

Production 103

Production Manufacturing Drugs Marketing 103

The Pharma Data

MARCH 8, 2022

The Label-CO-VAC is reviewing available data to optimize vaccine intermediated protection against current circulating variants. Still, to insure COVID-19 vaccines give optimal protection into the future, they may need to be streamlined as new, antigenically distinct variants crop.

Vaccination 52

Vaccination Vaccine Manufacturing Development 52

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. Meanwhile, China and Russia have rolled out state-owned vaccines. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year.

Sales 132

Sales Vaccination Vaccine Marketing 132

XTalks

APRIL 6, 2021

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. For food supply chain experts, the onset of the COVID-19 pandemic can be viewed as a stress test to our global food system, highlighting its strengths and its weak points. The same went for meat and dairy.

Production 104

Production Sales Vaccination Vaccine 104

Delveinsight

DECEMBER 3, 2020

Roche receives FDA authorization for the quantitative COVID-19 antibody test. Roche has got an authorization from the FDA for a more accurate COVID-19 blood test capable of measuring the levels of specific antibodies, which target the cell-unlocking spike protein of coronavirus. Merck chooses TriNKET cancer immunotherapy program.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

The Pharma Data

NOVEMBER 15, 2020

16, 2020 /PRNewswire/ — Cytiva , a global life sciences leader, is supporting Clover Biopharmaceuticals , a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate. . SHANGHAI , Nov.

Vaccination 52

Vaccination Vaccine Manufacturing Life Science 52

pharmaphorum

DECEMBER 2, 2020

And with the company becoming one of the first in the world to get a COVID-19 vaccine approved – via its collaboration with BioNTech – it feels like we’re only on the cusp of seeing where the company could head in the future. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag.

Sales 127

Sales Production Drugs Marketing 127

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. And 65% of pharma sales rep meetings were held virtually.

Clinical Trials 89

Clinical Trials Clinical Trials Development Marketing 89

The Pharma Data

APRIL 22, 2023

Many antibodies used to treat covid infection during the pandemic have been so-called neutralizing antibodies that prevent the virus from infecting the cell. But as the virus has mutated, the ability of these antibodies to bind to the virus has been lost, and thus also their protective effect.

Antibody 40

Antibody Immune Response Protein Research 40

pharmaphorum

FEBRUARY 26, 2021

COVID and beyond. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government. And at the tail end of 2020, a $6.5

Sales 119

Sales Production Pharma Companies Marketing 119

The Pharma Data

MARCH 20, 2021

The Challenge: The demands of many labs simultaneously beginning COVID-19 screening programs are leading to a scarcity of resources like pipette tips and reagents. an existing RT-qPCR workflow for COVID-19 testing, consistent and reliable contact-free dispensing. of Covid tests, clever. The diagnostic test is run under.

Reagent 52

Reagent RNA Bioinformatics Medicine 52

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 47%. . . . .

Vaccination 40

Vaccination Vaccine Production Sales 40

The Pharma Data

MAY 5, 2021

Lilly hit by staff accusations, FDA scrutiny at COVID drug factories ( Reuters ). White House will make unordered vaccine supply available to other states ( WaPo ). White House set to send vaccines abroad ( Politico ). White House set to send vaccines abroad ( Politico ).

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52

World of DTC Marketing

JUNE 16, 2021

The pharma industry has been riding a wave of public approval since they developed a vaccine to fight COVID-19, but that goodwill is going to be short lived thanks, in part, to the $56,000 price tag of Biogen’s new drug and insulin that too many people still can’t afford.

Drugs 180

Drugs Branding Medicine Insulin 180